DNS - Cefotaxim
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1824/2021/ÚVN + 12-247/2021-1470 + S-001697/21 | 31. 12. 2021 | PHARMOS, a.s. | 2 074 952,00 | 1 886 320,00 | 2 074 952,00 | 1 886 320,00 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| KS VNB Cefotaxim anonymized.pdf | Smlouva | 18. 01. 2022 10:45 | Dokument není zavirovaný | ||
| KS VNB info z RS.pdf | Smlouva | 18. 01. 2022 10:45 | Dokument není zavirovaný | ||
| KS VNOL Cefotaxim anonymized.pdf | Smlouva | 18. 01. 2022 10:45 | Dokument není zavirovaný | ||
| KS VNOL info z RS.pdf | Smlouva | 18. 01. 2022 10:45 | Dokument není zavirovaný |
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| Alliance Healthcare s. r. o. | Praha | |||||
| PHOENIX lékárenský velkoobchod, s.r.o. | Praha | |||||
| ViaPharma s.r.o. | Praha | |||||
| PHARMOS, a.s. | Ostrava |
Price Actually Paid in Each Year of Performance
| 1824/2021/ÚVN + 12-247/2021-1470 + S-001697/21 | 2023 | 284 822,79 | 258 929,53 |
| 1824/2021/ÚVN + 12-247/2021-1470 + S-001697/21 | 2022 | 188 043,50 | 170 948,64 |
| 1824/2021/ÚVN + 12-247/2021-1470 + S-001697/21 | 2021 | 43 873,91 | 39 885,37 |